SCHEMBL7133282

SCHEMBL7133282

CNS(=O)(=O)c1ccc2c(c1)C(=Cc1cccc(Oc3ccc(C)cc3)c1)C(=O)N2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 2/20 0.51
SYK P43405 2/20 0.51
FCER2 P06734 1/20 0.51
NTRK3 Q16288 1/20 0.51
NTRK2 Q16620 1/20 0.51
SRC P12931 6/20 0.48
KDR P35968 4/20 0.48
CDK2 P24941 2/20 0.48
ADAMTS5 Q9UNA0 1/20 0.47
MEN1 O00255 1/20 0.46
NPC1 O15118 1/20 0.46
POLB P06746 1/20 0.46
RAB9A P51151 1/20 0.46
KMT2A Q03164 1/20 0.46
MAOA P21397 1/20 0.44
MAOB P27338 1/20 0.44
LCK P06239 3/20 0.43
FYN P06241 3/20 0.43
YES1 P07947 3/20 0.43
PDGFRB P09619 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5368747 0.93 SRC (0.51) NTRK1SYKFCER2NTRK3NTRK2
SCHEMBL7131357 0.92 SYK (0.57) NTRK1SYKFCER2NTRK3NTRK2
SCHEMBL7130884 0.90 ADAMTS5 (0.51) NTRK1SYKFCER2NTRK3NTRK2
SCHEMBL7137038 0.89 SYK (0.49) NTRK1SYKFCER2NTRK3NTRK2
SCHEMBL7132123 0.87 SYK (0.62) NTRK1SYKFCER2NTRK3NTRK2
SCHEMBL7136635 0.87 NTRK1 (0.55) NTRK1SYKFCER2NTRK3NTRK2
SCHEMBL7132857 0.86 SYK (0.47) NTRK1SYKFCER2NTRK3NTRK2
SCHEMBL7136938 0.84 MOGAT2 (0.50) CDK2ADAMTS5MEN1NPC1POLB
SCHEMBL7136883 0.84 SRC (0.58) NTRK1SYKFCER2NTRK3NTRK2
SCHEMBL7133195 0.82 MAOA (0.50) NTRK1SYKFCER2NTRK3NTRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6506763-B2 Useful in prevention and treatment of protein kinase related disorders such as cancer SUGEN, INC. 2003-01-14 US disclosed
EP-0984930-A1 2-INDOLINONE DERIVATIVES AS MODULATORS OF PROTEIN KINASE ACTIVITY Sugen, Inc. (US) 2000-03-15 EP disclosed
WO-1998050356-A1 2-INDOLINONE DERIVATIVES AS MODULATORS OF PROTEIN KINASE ACTIVITY SUGEN, INC. (US) 1998-11-12 WO disclosed